Aesthetic plastic surgery
-
Aesthetic plastic surgery · Jan 2004
Clinical Trial Controlled Clinical TrialOndansetron for the prevention of postoperative nausea and vomiting: which is the best dosage for aesthetic plastic surgery?
Ondansetron has been used widely in plastic surgery to prevent postoperative nausea and vomiting. A literature search showed controversial dosages of this drug, and because of its short half-life, its use only before anesthetic induction could have a limited effect. The purpose of this study was to assess the efficacy of intravenous (IV) ondansetron (4 mg) for aesthetic plastic surgery performed with the patient under general anesthesia and the prophylaxis of postoperative nausea and vomiting (PONV) in two situations: (a) only before anesthetic induction and (b) before anesthetic induction and immediately before extubation. ⋯ According to the findings, there was no statistical difference between the groups. However, the dosage used in the control group was effective and less expensive.
-
Aesthetic plastic surgery · Jan 2004
Postoperative nausea and vomiting in the plastic surgery patient.
Despite great advances in modern medicine, postoperative nausea and vomiting (PONV) continue to be a significant problem without a definitive cure. This article describes a prospective study conducted with 143 plastic surgery patients at a single institution between 1998 and 2000 to identify preoperative risk factors for PONV that may be specific to plastic surgery patients. In addition, a prophylactic regimen was identified that demonstrated a decrease in the incidence of PONV from the published incidence of 22% to 3%. The regimen includes the use of multiple antiemetic agents including ondansetron (Zofran) promethazine (Phenergan), and metoclopramide (Reglan), with the addition of dexamethasone (Decadron) in selected cases